Bimatoprost Sustained Release Implant
Pre-clinicalCompleted 0 watching 0 views this week💤 Quiet
23
Development Stage
1
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Open-angle Glaucoma
Conditions
Open-angle Glaucoma
Trial Timeline
— → —
NCT ID
NCT05338606About Bimatoprost Sustained Release Implant
Bimatoprost Sustained Release Implant is a pre-clinical stage product being developed by AbbVie for Open-angle Glaucoma. The current trial status is completed. This product is registered under clinical trial identifier NCT05338606. Target conditions include Open-angle Glaucoma.
Hype Score Breakdown
Clinical
5
Activity
2
Company
10
Novelty
2
Community
1
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT05338606 | Pre-clinical | Completed |
Competing Products
20 competing products in Open-angle Glaucoma